Taito Esaki

机构：National Kyushu Medical Center, National Hospital Organization Kyushu Cancer Center · ORCID：0000-0002-9169-8453

发表论文 432 篇 · 总被引 10376 次 · h-index 45

代表论文

• Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer (2025 · Journal of Clinical Oncology · 被引 15)
• Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial (2025 · The Lancet Oncology · 被引 12)
• ONO ‐4578 Plus Nivolumab in Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer (2025 · Cancer Science · 被引 8)
• Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan (2025 · International Journal of Clinical Oncology · 被引 4)
• Association Between Frailty and Patients' Experience of Cancer Treatment and Care (2025 · Journal of the American Geriatrics Society · 被引 2)
• Circulating tumor DNA (ctDNA) clearance as an early indicator of sotorasib + panitumumab efficacy and prognosis in KRAS G12C–mutated colorectal cancer (mCRC): Results from phase 3 CodeBreaK 300. (2026 · Journal of Clinical Oncology · 被引 1)